Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · IEX Real-Time Price · USD
26.03
+0.18 (0.70%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Anika Therapeutics Revenue
Anika Therapeutics had revenue of $169.26M in the twelve months ending March 31, 2024, with 7.49% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $40.52M with 6.85% year-over-year growth. In the year 2023, Anika Therapeutics had annual revenue of $166.66M with 6.67% growth.
Revenue (ttm)
$169.26M
Revenue Growth
+7.49%
P/S Ratio
2.28
Revenue / Employee
$474,120
Employees
357
Market Cap
386.74M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 166.66M | 10.43M | 6.67% |
Dec 31, 2022 | 156.24M | 8.44M | 5.71% |
Dec 31, 2021 | 147.79M | 17.34M | 13.29% |
Dec 31, 2020 | 130.46M | 15.85M | 13.83% |
Dec 31, 2019 | 114.61M | 9.06M | 8.58% |
Dec 31, 2018 | 105.56M | -7.87M | -6.93% |
Dec 31, 2017 | 113.42M | 10.04M | 9.71% |
Dec 31, 2016 | 103.38M | 10.38M | 11.16% |
Dec 31, 2015 | 93.00M | -12.60M | -11.93% |
Dec 31, 2014 | 105.60M | 30.51M | 40.64% |
Dec 31, 2013 | 75.08M | 3.72M | 5.22% |
Dec 31, 2012 | 71.36M | 6.58M | 10.16% |
Dec 31, 2011 | 64.78M | 9.22M | 16.60% |
Dec 31, 2010 | 55.56M | 15.42M | 38.42% |
Dec 31, 2009 | 40.14M | 4.36M | 12.17% |
Dec 31, 2008 | 35.78M | 4.95M | 16.06% |
Dec 31, 2007 | 30.83M | 3.99M | 14.86% |
Dec 31, 2006 | 26.84M | -2.99M | -10.04% |
Dec 31, 2005 | 29.83M | 3.37M | 12.73% |
Dec 31, 2004 | 26.47M | 11.06M | 71.81% |
Dec 31, 2003 | 15.40M | 2.22M | 16.81% |
Dec 31, 2002 | 13.19M | 1.88M | 16.58% |
Dec 31, 2001 | 11.31M | -5.02M | -30.75% |
Dec 31, 2000 | 16.34M | 2.51M | 18.15% |
Dec 31, 1999 | 13.83M | 895.28K | 6.92% |
Dec 31, 1998 | 12.93M | 975.03K | 8.16% |
Dec 31, 1997 | 11.96M | 10.74M | 886.38% |
Dec 31, 1996 | 1.21M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
ModivCare | 2.78B |
Emergent BioSolutions | 1.19B |
Sonida Senior Living | 260.69M |
Editas Medicine | 69.41M |
AC Immune | 16.82M |
Fate Therapeutics | 6.48M |
Precigen | 5.44M |
Daré Bioscience | 2.82M |
ANIK News
- 1 day ago - Orthopedic Regenerative Surgical Products Market Size to Reach USD 6.6 Billion By 2033, at 4.4 CAGR: Insights by Dimension Market Research - GlobeNewsWire
- 25 days ago - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Anika Enters into Cooperation Agreement with Caligan Partners - GlobeNewsWire
- 7 weeks ago - Anika Announces CFO Transition - GlobeNewsWire
- 7 weeks ago - Anika Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024 - GlobeNewsWire
- 3 months ago - Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 3 months ago - Anika Reports Fourth Quarter and Year-End 2023 Financial Results - GlobeNewsWire